Live birth or ongoing pregnancy · ovarian stimulation protocols for women undergoing ART
Progestogen showed no clear difference in live birth or ongoing pregnancy (Prog + Ant vs Ant) compared with placebo or no pretreatment (low certainty).
2 findings from 1 review
Pregnancy loss · ovarian stimulation protocols for women undergoing ART
Progestogen showed no clear difference in pregnancy loss (Prog + Ag vs Ag) compared with placebo or no pretreatment (low certainty).
2 findings from 1 review
Multiple pregnancy rate · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
OHSS · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Live birth or ongoing pregnancy · ovarian stimulation protocols for women undergoing ART
Oestrogen showed no clear difference in live birth or ongoing pregnancy (Oestr + Ant vs Ant) compared with no pretreatment (moderate certainty).
2 findings from 1 review
Pregnancy loss · ovarian stimulation protocols for women undergoing ART
It is very uncertain whether oestrogen changes pregnancy loss (Oestr + Ant vs Ant) compared with no pretreatment (very low certainty).
2 findings from 1 review
Multiple pregnancy rate · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
OHSS rate (Oestr + Ant vs Ant) · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
OHSS · ovarian stimulation protocols for women undergoing ART
It is very uncertain whether oestrogen changes OHSS rate (Oestr + Ant vs Ag) compared with no pretreatment (very low certainty).
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with a serious adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
At least 50% of maximum pain relief over 4 to 6 hours · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Median (mean) time to use of rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Number of women requiring rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with ≥ 1 adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with a serious adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
At least 50% of maximum pain relief over 4 to 6 hours · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Median (mean) time to use of rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Number of women requiring rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with ≥ 1 adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review